Search

Your search keyword '"Mckeown, Michael"' showing total 772 results

Search Constraints

Start Over You searched for: Author "Mckeown, Michael" Remove constraint Author: "Mckeown, Michael"
772 results on '"Mckeown, Michael"'

Search Results

2. Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML

3. Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist.

4. Essentials of Mental Health Nursing (2nd Edition)

8. Humour in forensic services: Enabling connections between patients and students

9. A hermeneutic phenomenological exploration of patients’ and student nurses’ experiences of the time they share together on personality disorder forensic units

10. The impact of patients and student mental health nurses sharing time together in forensic units

13. The Ethical Mental Health Nurse

14. Non-Medical Alternatives for Crisis Care

19. Independent Advocacy in Mental Health Care

25. Mental Health Risk Assessment: A Personalised Approach

27. Discovery of KB-0742, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of CDK9 for MYC-Dependent Cancers

28. Improving FRET dynamic range with bright green and red fluorescent proteins

34. Supplementary Table S3: Median Survival By Cluster from Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist

35. Supplementary Table S2: mRNA Cluster Signatures from Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist

36. Supplementary Table S1: Sample mutations from Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist

37. Supplementary Table S4: Enhancer, mRNA, and SY-1425 EC50 in AML cell lines from Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist

38. Supplementary Methods and Figure Legends from Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist

39. Supplementary Table S7: GREAT analysis from Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist

40. Data from Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist

41. Supplementary Figures from Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist

42. Supplementary Table S5 & 6: GSEA of SY-1425 response from Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist

44. Relational practice in health, education, criminal justice and social care: A Scoping Review

45. The Mental Health And Wellbeing Impact of A Community Wealth Building Programme – A Difference-In-Differences Study

46. A pedagogic evaluation comparing face to face and online formats of a Multi-Professional Offender Personality Disorder (OPD) Higher Education Training programme

47. Participatory action research to co-design a culturally appropriate COVID-19 risk communication and community engagement strategy in rural Pakistan

49. Experiencing restraint: A dialogic narrative inquiry from a service user perspective

50. On the bullshitisation of mental health nursing: a reluctant work rant

Catalog

Books, media, physical & digital resources